ask="N/A"
ask_size="N/A"
average_daily_volume="65806"
bid="N/A"
bid_size="N/A"
book_value="6.38"
change="+0.37"
change_from_200_day_moving_average="1.78"
change_from_50_day_moving_average="0.74"
change_from_52_week_high="-2.59"
change_From_52_week_low="5.09"
change_in_percent="+2.08%"
close="18.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="18.22"
high_52_weeks="20.74"
last_trade_date="1/10/2017"
last_trade_price="18.15"
last_trade_size="3616"
last_trade_time="4:00pm"
low="17.25"
low_52_weeks="13.06"
market_capitalization="394.31M"
moving_average_200_day="16.37"
moving_average_50_day="17.41"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="17.39"
pe_ratio="N/A"
peg_ratio="-1.69"
percent_change_from_200_day_moving_average="+10.86%"
percent_change_from_50_day_moving_average="+4.26%"
percent_change_from_52_week_high="-12.49%"
percent_change_from_52_week_low="+38.97%"
previous_close="17.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="7.16"
stock_exchange="NGM"
symbol="BOLD"
volume="20542"
weeks_range_52="13.06 - 20.74"
